AIRSUPRA
SABAICS MDI
Albuterol / Budesonide · AstraZeneca
Active Medication & Mechanism
- Albuterol sulfate SABA90 mcg albuterol per actuation
Short-acting beta2-adrenergic agonist. Relaxes bronchial smooth muscle by activating beta2-receptors, increasing cAMP, and producing rapid bronchodilation within minutes.
- Budesonide ICS80 mcg per actuation
Corticosteroid with anti-inflammatory properties. Reduces airway inflammation and edema to help prevent worsening of symptoms during acute episodes.
FDA-Approved Dosing — Strength × Indication
Strength Regimen Asthma
90/80 mcg
2 inhalations as needed for bronchoconstriction symptoms → Maximum 12 inhalations (1080/960 mcg) per 24 hours
FDA Approved
For the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in adults with asthma. Not for scheduled maintenance use.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
90/80 mcg 2 inhalations as needed for bronchoconstriction symptoms → Maximum 12 inhalations (1080/960 mcg) per 24 hours
Asthma FDA Approved
For the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in adults with asthma. Not for scheduled maintenance use.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Rescue inhaler. Indicated for as-needed treatment or prevention of bronchoconstriction and to reduce exacerbation risk in asthma. Not for scheduled maintenance therapy.